Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Equity Ratio (2021 - 2025)

Historic Equity Ratio for Verrica Pharmaceuticals (VRCA) over the last 5 years, with Q3 2025 value amounting to 0.42.

  • Verrica Pharmaceuticals' Equity Ratio rose 5970.87% to 0.42 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.42, marking a year-over-year increase of 5970.87%. This contributed to the annual value of 0.18 for FY2024, which is 17520.18% down from last year.
  • Per Verrica Pharmaceuticals' latest filing, its Equity Ratio stood at 0.42 for Q3 2025, which was up 5970.87% from 0.45 recorded in Q2 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Equity Ratio peaked at 0.94 during Q1 2023, and registered a low of 1.03 during Q3 2024.
  • For the 5-year period, Verrica Pharmaceuticals' Equity Ratio averaged around 0.22, with its median value being 0.35 (2022).
  • As far as peak fluctuations go, Verrica Pharmaceuticals' Equity Ratio surged by 24592.52% in 2023, and later tumbled by 203653.01% in 2025.
  • Over the past 5 years, Verrica Pharmaceuticals' Equity Ratio (Quarter) stood at 0.41 in 2021, then surged by 119.98% to 0.9 in 2022, then crashed by 72.94% to 0.24 in 2023, then crashed by 175.2% to 0.18 in 2024, then tumbled by 128.76% to 0.42 in 2025.
  • Its Equity Ratio stands at 0.42 for Q3 2025, versus 0.45 for Q2 2025 and 0.44 for Q1 2025.